Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05057546 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Sep 30, 2024 to Sep 18, 2024 Completion date: Sep 30, 2024 to Jul 28, 2025v9 Show 1 more changeShow less
    • Completion date: Sep 30, 2024 to Jul 28, 2025
  2. Trial status: Recruiting to Active, Not Recruiting Site details revisedv8 Show 1 more changeShow less
    • Site details revised
  3. Eligibility criteria expanded, about 33 wordsv7 See this version in full on ClinicalTrials.gov ↗
  4. 3 versions Re-verified since Jan 4, 2022, no change to tracked fieldsv4-v6
  5. Trial status: Not Yet Recruiting to Recruiting Start date: Nov 2021 to Nov 22, 2021 · Site details revisedv3 Show 2 more changesShow less
    • Start date: Nov 2021 to Nov 22, 2021
    • Site details revised
  6. Start date: Oct 1, 2021 to Nov 2021v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will evaluate changes in blood vessels around the heart (e.g., aorta and carotid arteries) and in the brain with the loss of female sex hormones (e.g., estrogen) during the menopause transition. The menopause transition is associated with declines in blood vessel function and increased risk for cardiovascular disease and Alzheimer's disease. Increasing evidence supports an early role for declines in blood vessel function and future development of Alzheimer's disease in aging men and women. This study will learn about the effects of changes in female sex hormones, such as estrogen, during the menopause transition on blood vessel around the heart and in the brain in women.
Trial Details
NCT Number NCT05057546
Lead Sponsor University of Colorado, Denver
Conditions Menopause, Estrogen Deficiency, Women, Aging
Enrollment 55 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov